Medi Assist Healthcare Services Ltd - 544088 - Announcement under Regulation 30 (LODR)-Investor Presentation
"Medi Assist Healthcare Services Limited - Investor Presentation Q4 & FY2024"16-05-2024
Medi Assist Healthcare Services Ltd - 544088 - Announcement under Regulation 30 (LODR)-Investor Presentation
"Medi Assist Healthcare Services Limited - Investor Presentation Q4 & FY2024"Q4FY24 Quarterly & FY24 Annual Result Announced for Medi Assist Healthcare Services Ltd.
Healthcare Services company Medi Assist Healthcare Services announced Q4FY24 & FY24 results: Q4FY24 Financial Highlights: Total Income is Rs 171.1 crore, a growth of 22.9% over the corresponding quarter of the previous year Revenue from contracts with customers excluding other income (“Operating Revenue”) is Rs 166.8 crore, a growth of 22.6% over the corresponding quarter of the previous year Revenue from contracts with customers included: 11.4% from Government business 5.2% from International benefits business EBITDA excluding Other Income (“Operating EBITDA”) is Rs 37.0 crore a growth 20.7% YoY over the corresponding quarter of the previous year a margin of 22.2% on Operating Revenue Profit after tax is Rs 25.7 crore, at 15% Margin on Total Income a growth of 50.6% YoY over the corresponding quarter of the previous year a margin improvement of 277bps YoY FY24 Financial Highlights: Revenue from contracts with customers excluding other income (“Operating Revenue”) is Rs 634.7 crore, a growth of 25.7% over the previous year Revenue from contracts with customers included: 10.1% from Government business 5.8% from international benefits business EBITDA excluding Other Income (“Operating EBITDA”) is Rs 133.3 crore a growth of 11.7% YoY over the previous year a margin of 21.0% on Operating Revenue Profit for the period (adjusting for exceptional item) is Rs 92.3 crore a growth of 22.6% over the previous year a margin of 14.1% on Total Income Key Balance sheet and operating metrics for FY24 are as follows: Net cash balance in the books is Rs 245 crore Net Worth is Rs 481 crore, Return on Net Worth is 19.2% Return on Capital employed is 20.4% Revenue per average headcount (on non-government contracts) is Rs 1.38 million Satish Gidugu, CEO, said, “Medi Assist has delivered another year of strong growth, with a 3 year revenue CAGR of over 25%, backed by the trust we continue to enjoy from our customers. Our organic growth clubbed with successful integration of acquisitions stand testament to our performance.” Result PDFMedi Assist Healthcare Services Ltd - 544088 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on the audited financials for the quarter and year ended March 31, 2024Medi Assist Healthcare Services Ltd - 544088 - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 -Employee Stock Option Scheme 2013 Of The Company
Intimation under Reg 30 of SEBI (LODR) regulations 2015 regarding ESOP scheme of the CompanyMedi Assist Healthcare Services Ltd - 544088 - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Reconstitution Of Audit Committee Of The Company
Intimation under Reg 30 of SEBI(LODR) Regulations 2015-Reconstitution of Audit Committee of the CompanyMedi Assist Healthcare Services Ltd - 544088 - Corporate Action-Board approves Dividend
Recommendation of Final DividendMedi Assist Healthcare Services Ltd - 544088 - Announcement under Regulation 30 (LODR)-Change in Management
Appointment of Internal and Secretarial Auditor for the F.Y.2024-25Medi Assist Healthcare Services Ltd - 544088 - Announcement under Regulation 30 (LODR)-Change in Management
Change in Chief Financial OfficerMedi Assist Healthcare Services Ltd - 544088 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 15, 2024
Outcome of Board Meeting held on May 15, 2024Medi Assist Healthcare Services Ltd - 544088 - Audited Financial Results For The Financial Year Ended March 31, 2024
Audited financial results for the Financial year ended March 31, 2024